Immunodiagnosis and Immunotherapy of Patients with Alzheimer’s Syndrome

[1]  C. Broeckhoven,et al.  Failure of familial Alzheimer's disease to segregate with the A4-amyloid gene in several European families , 1987, Nature.

[2]  J. Haines,et al.  The genetic defect in familial Alzheimer's disease is not tightly linked to the amyloid β-protein gene , 1987, Nature.

[3]  R. Benner,et al.  Deterioration of cellular immunity during aging. The relationship between age-dependent impairment of delayed-type hypersensitivity reactivity, interleukin-2 production capacity, and frequency of Thy-1+,Lyt-2- cells in C57BL/Ka and CBA/Rij mice. , 1987, Cellular immunology.

[4]  H. Fudenberg,et al.  Generation of phenotypically distinct macrophage-hepatoma hybrid clones. , 1987, Immunobiology.

[5]  B. Cohen,et al.  Platelet membrane fluidity in Alzheimer's disease and major depression. , 1987, The American journal of psychiatry.

[6]  P. White,et al.  Congenital adrenal hyperplasia. (First of two parts) , 1987 .

[7]  M. Dąbrowski,et al.  Immunologic and Clinical Evaluation of Multiple Sclerosis Patients Treated with Corticosteroids and/or Calf Thymic Hormones , 1987, Annals of the New York Academy of Sciences.

[8]  F. R. Brown,et al.  Immunologic dysfunction: simultaneous study of alzheimer's and older down's patients , 1987, Mechanisms of Ageing and Development.

[9]  Fudenberg Hh,et al.  Can blood immunocytes be used to study neuropsychiatric disorders , 1986 .

[10]  A. Weetman,et al.  The IgG subclass distribution of thyroid autoantibodies. , 1986, Immunology letters.

[11]  G. Canonica,et al.  Does normal lymphocyte DNA synthesis in response to PHA exclude cell-mediated immunodepression? , 1986, Clinical immunology and immunopathology.

[12]  D. Gajdusek,et al.  Antibodies to neurofilament protein in retinitis pigmentosa. , 1986, The Journal of clinical investigation.

[13]  V. Singh,et al.  Detection of brain autoantibodies in the serum of patients with Alzheimer's disease but not Down's syndrome. , 1986, Immunology letters.

[14]  David M. A. Mann,et al.  The neuropathology of Alzheimer's disease: A review with pathogenetic, aetiological and therapeutic considerations , 1985, Mechanisms of Ageing and Development.

[15]  H. Wiśniewski,et al.  Current Hypothesis of the Etiology and Pathogenesis of Senile Dementia of the Alzheimer Type , 1985 .

[16]  G. Glenner On causative theories in Alzheimer's disease. , 1985, Human pathology.

[17]  D. Gajdusek,et al.  The 200- and 150-kDa neurofilament proteins react with IgG autoantibodies from patients with kuru, Creutzfeldt-Jakob disease, and other neurologic diseases. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[18]  E. Bandle,et al.  2-Pyrrolidinone and succinimide endogenously present in several mammalian species. , 1984, Life sciences.

[19]  G. Zubenko Dr. Zubenko Replies , 1984 .

[20]  P. Arnaud,et al.  Is Alzheimer's disease an immunological disorder? Observations and speculations. , 1984, Clinical immunology and immunopathology.

[21]  W. Fierz,et al.  Astrocytes present myelin basic protein to encephalitogenic T-cell lines , 1984, Nature.

[22]  O. Beck Distribution of virus antibody activity among human IgG subclasses. , 1981, Clinical and experimental immunology.

[23]  M. Weksler The Immune System and the Aging Process in Man 1 , 1980, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[24]  S. Weitzman,et al.  Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigens. , 1980, The New England journal of medicine.

[25]  V. Singh,et al.  Increase of immunoglobulin G3 subclass is related to brain autoantibody in Alzheimer's disease but not in Down's syndrome. , 1989, Autoimmunity.

[26]  S. Gammeltoft,et al.  Acetylcholine receptor antibody in myasthenia gravis: predominance of IgG subclasses 1 and 3. , 1987, Clinical and experimental immunology.

[27]  M. French Immunoglobulins in Health and Disease , 1986, Immunology and Medicine Series.

[28]  L. Hammarström,et al.  Immunoglobulin Isotype Diversity and its Functional Significance , 1986 .

[29]  V. Singh,et al.  Immunopharmacological approach to the study of chronic brain disorders. , 1986, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.

[30]  R. Dawkins,et al.  CHAPTER 22 – Autoimmune Diseases of Muscle: Myasthenia Gravis and Myositis* , 1985 .

[31]  B. Arnason CHAPTER 15 – Multiple Sclerosis, Allied Central Nervous System Diseases, and Immune-Mediated Neuropathies , 1985 .

[32]  P. Arnaud,et al.  Immune diagnosis of a subset of Alzheimer's disease with preliminary implications for immunotherapy. , 1984, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[33]  A. Ugazio,et al.  Down syndrome: a model of immunodeficiency. , 1983, Birth defects original article series.

[34]  D. Segre,et al.  Immunological aspects of aging , 1981 .

[35]  Daniel P. Stites,et al.  Basic and Clinical Immunology , 1976 .